The goal of this clinical trial is to compare the effect of perioperative immunonutrition supplement in gynecologic cancer patients. The main questions it aims to answer are: * is there any difference in the nutritional outcomes and functional outcomes between intervention and conventional groups? * is there any difference in the post-surgical outcomes between intervention and conventional groups? Participants (intervention) will be provided the immunonutrition supplement before and after operation. Researchers will compare intervention group with conventional group to see if there is any difference in postoperative outcomes.
The clinical trial aims to determine the effectiveness of perioperative IMN intervention on postoperative outcomes among GC patients under Enhanced Recovery after Surgery (ERAS) setting. Patients will prescribed with immunonutrition supplement before and after surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
106
Participant will prescribed with 2 servings of immunonutrition supplement 5 days before surgery and 7 days after surgery
Institut Kanser Negara
Putrajaya, Putrajaya, Malaysia
RECRUITINGdaily energy and protein intake
24-hours diet recall
Time frame: 1 month
body composition
body composition analyzer; weight in kg; fat free mass in kg; fat mass in kg; muscle mass in kg; height in meter
Time frame: 1 month
immunoglobulin level
Concentration of immunoglobulin G; Concentration of immunoglobulin A; Concentration of immunoglobulin M
Time frame: 1 month
C-reactive protein
Concentration of C-reactive protein
Time frame: 1 month
postoperative outcomes
length of hospitalization
Time frame: 1 months
Functional status
handgrip strength in kg via Jammar dynamometer
Time frame: 1 month
stress level
questionnaire 10-item perceived stress scale (PSS-10) form
Time frame: 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.